Background. Non-small cell lung cancer (NSCLC) is the most prevalent malignant tumor of
the lung cancer, for which the molecular mechanisms remain unknown. In this study, we …

Background Lung cancer is the most common cause of cancer‐related death among all
human cancers and the five‐year survival rates are only 23%. The precise molecular …

Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all
patients with lung cancer and 5-year relative overall survival (OS) rate is less than 20%, so …

Lung cancer is one of the most widespread neoplasms worldwide. To identify the key
biomarkers in its carcinogenesis and development, the mRNA microarray datasets …

Objective Non-small-cell lung cancer (NSCLC) accounts for> 85% of lung cancers, and its
incidence is increasing. We explored expression differences between NSCLC and normal …

Background Lung cancer, a malignant tumor, has the highest mortality and second most
common morbidity worldwide. Non-small cell lung cancer (NSCLC) is the most common …

Background Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer
morbidity and mortality worldwide. In the present study, we identified novel biomarkers …

Background Identification of accurate prognostic biomarkers is still particularly urgent for
improving the poor survival of lung cancer patients. In this study, we aimed to identity the …

Non‐small‐cell lung cancer (NSCLC) is one of the main causes of death induced by cancer
globally. However, the molecular aberrations in NSCLC patients remain unclearly. In the …

Lung cancer is one of the most malignant tumors in the world. Early diagnosis and treatment
of lung cancer are vitally important to reduce the mortality of lung cancer patients. In the …